From fundamental mechanisms to clinical implications, ISSBM13 will be a dynamic platform to share the latest findings and foster collaborations across fields. ✨ I hope to see many of you there in Korea!. #ISSBM2025 #SeleniumBiology #BiomedicalResearch #RedoxBiology #KAIST.

This unique international symposium brings together a diverse community of researchers across disciplines, including: Biologists, Chemists, Medical researchers and etc. — all united by a common interest in understanding the roles of selenium in health and disease.

I'm excited to share that the 13th International Symposium on Selenium in Biology and Medicine (ISSBM 13) will be held on October 26–29, 2025 at KAIST, Daejeon, South Korea 🇰🇷.👉Web link: Promotion video:

RT @bstockwell: Only 4 days left to register. I hope to see many new ferroptosis researchers in Chicago!.

RT @antioxidants_OA: 🌟 Congratulations to @NamgyuLee1 , our 2023 Young Investigator Award winner! 🏆🎉. 👏 Join us in celebrating this incredi….

Don’t miss this chance to expand your research horizons! 🌍. #YSP2025 #FAOBMB #YoungScientists #Networking #EarlyCareerResearchers #Biochemistry #MolecularBiology #GlobalScience #Busan2025.

🌐 Build your global network, share your research with an international audience, and explore career-advancing workshops before the 31st FAOBMB Conference! Travel Fellowships are available to support your participation.

🎓 Eligible countries include Australia, Bangladesh, China, Hawaii, Hong Kong, India, Indonesia, Iran, Japan, Korea, Malaysia, Myanmar, Nepal, New Zealand, Pakistan, Philippines, Singapore, Sri Lanka, Taipei, Thailand, and Vietnam.

🌟 Exciting Opportunity for Young Scientists! 🌟Selected early-career researchers and PhD candidates are invited to join a 2-day scientific and networking event in Busan, South Korea, from May 18-20, 2025. 📅 Deadline Extended: Apply by 15 November 2024!.

RT @OlzmannLab: Please RT and help us get the word out. Scott Dixon @sjd956 and I are co-organizing the first @FASEBorg #Ferroptosis confer….

RT @OlzmannLab: Mark your calendars! The 1st FASEB #Ferroptosis conference, July 27-31 2025! We just posted our preliminary agenda! Spectac….

RT @Conrad_Lab: Very cool - congratulations! First ferroptosis conference in the 🇺🇸 Looking forward to it!.

RT @HaoChingJiang1: I am thrilled to announce that my PhD research has been published online in @NatureComms today. .

RT @OlzmannLab: Thrilled to see our new review "The Cell Biology of Ferroptosis" w/ Scott Dixon (@SJD956) is online! We discuss the executi….

I presented our recent findings at the @UMassChan Medical School today and the Boston/Harvard Cell Death Initiative last week. I appreciate the opportunity to present and thank you for all the insightful questions and comments😃!

Thanks, Dr. Ian G. Chambers and Dr. Rajiv R. Ratan, for writing News & View about our paper!.

This process leads to the formation of ubiquinol, ultimately safeguarding cells from mitochondrial lipid peroxidation. Through this paper, we unveil an unprecedented facet of selenium and introduce SQOR as a novel regulator in the context of ferroptosis.

However, our study reveals a novel aspect wherein selenide, a metabolic intermediate in the selenocysteine synthesis pathway, donates electrons to ubiquinone in an SQOR enzyme-dependent manner.

In this paper, we elucidate the non-canonical anti-ferroptosis mechanism of selenium. Traditionally, selenium's cytoprotective role has been attributed to its involvement in selenocysteine tRNA synthesis, essential for the production of 25 selenoproteins, including GPX4.

Our paper has been published today in Nature Metabolism! I extend my sincere thanks to all authors: @SungJin2619, @MikeLangePhD , T. Tseyang, @ScienceGraduate, T.Y. Kim, Y. Song, D.I. Kim, @Greer_Lab , @OlzmannLab , @JBSpinelli , and Dohoon Kim.